TRIS PHARMA INC FDA Approval ANDA 091135

ANDA 091135

TRIS PHARMA INC

FDA Drug Application

Application #091135

Documents

Letter2012-05-30
Review2017-05-17

Application Sponsors

ANDA 091135TRIS PHARMA INC

Marketing Status

Over-the-counter001

Application Products

001SUSPENSION, EXTENDED RELEASE;ORALEQ 30MG HYDROBROMIDE/5ML0DEXTROMETHORPHAN POLISTIREXDEXTROMETHORPHAN POLISTIREX

FDA Submissions

ORIG1AP2012-05-25
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2014-10-27

Submissions Property Types

ORIG1Null7
SUPPL2Null7

CDER Filings

TRIS PHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91135
            [companyName] => TRIS PHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"DEXTROMETHORPHAN POLISTIREX","activeIngredients":"DEXTROMETHORPHAN POLISTIREX","strength":"EQ 30MG HYDROBROMIDE\/5ML","dosageForm":"SUSPENSION, EXTENDED RELEASE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"DEXTROMETHORPHAN POLISTIREX","submission":"DEXTROMETHORPHAN POLISTIREX","actionType":"EQ 30MG HYDROBROMIDE\/5ML","submissionClassification":"SUSPENSION, EXTENDED RELEASE;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.